Your search returned 11 results.

Results
	1.	Development of onabotulinumtoxinA for chronic migraine. [electronic resource] by Whitcup, Scott M Turkel, Catherine C DeGryse, Ronald E Brin, Mitchell F Producer: 20150126 In: Annals of the New York Academy of Sciences vol. 1329 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Validation of the Headache Impact Test (HIT-6) in patients with chronic migraine. [electronic resource] by Rendas-Baum, Regina Yang, Min Varon, Sepideh F Bloudek, Lisa M DeGryse, Ronald E Kosinski, Mark Producer: 20150518 In: Health and quality of life outcomes vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine over one year of treatment: Pooled results from the PREEMPT randomized clinical trial program. [electronic resource] by Lipton, Richard B Rosen, Noah L Ailani, Jessica DeGryse, Ronald E Gillard, Patrick J Varon, Sepideh F Producer: 20170314 In: Cephalalgia : an international journal of headache vol. 36 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Early onset of effect of onabotulinumtoxinA for chronic migraine treatment: Analysis of PREEMPT data. [electronic resource] by Dodick, David W Silberstein, Stephen D Lipton, Richard B DeGryse, Ronald E Adams, Aubrey Manack Diener, Hans-Christoph Producer: 20201023 In: Cephalalgia : an international journal of headache vol. 39 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Botulinum toxin type A for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial. [electronic resource] by Silberstein, Stephen D Stark, Stuart R Lucas, Sylvia M Christie, Suzanne N Degryse, Ronald E Turkel, Catherine C Producer: 20051011 In: Mayo Clinic proceedings vol. 80 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Per cent of patients with chronic migraine who responded per onabotulinumtoxinA treatment cycle: PREEMPT. [electronic resource] by Silberstein, Stephen D Dodick, David W Aurora, Sheena K Diener, Hans-Christoph DeGryse, Ronald E Lipton, Richard B Turkel, Catherine C Producer: 20151109 In: Journal of neurology, neurosurgery, and psychiatry vol. 86 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. [electronic resource] by Dodick, David W Turkel, Catherine C DeGryse, Ronald E Aurora, Sheena K Silberstein, Stephen D Lipton, Richard B Diener, Hans-Christoph Brin, Mitchell F Producer: 20101008 In: Headache vol. 50 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	OnabotulinumtoxinA for treatment of chronic migraine: a response. [electronic resource] by Dodick, David W Turkel, Catherine C Degryse, Ronald E Aurora, Sheena K Silberstein, Stephen D Lipton, Richard B Diener, Hans-Christoph Brin, Mitchell F Producer: 20130729 In: Headache vol. 51 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Assessing clinically meaningful treatment effects in controlled trials: chronic migraine as an example. [electronic resource] by Dodick, David W Turkel, Catherine C DeGryse, Ronald E Diener, Hans-Christoph Lipton, Richard B Aurora, Sheena K Nolan, Marissa E Silberstein, Stephen D Producer: 20160219 In: The journal of pain vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program. [electronic resource] by Aurora, Sheena K Winner, Paul Freeman, Marshall C Spierings, Egilius L Heiring, Jessica O DeGryse, Ronald E VanDenburgh, Amanda M Nolan, Marissa E Turkel, Catherine C Producer: 20120914 In: Headache vol. 51 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline. [electronic resource] by Silberstein, Stephen D Blumenfeld, Andrew M Cady, Roger K Turner, Ira M Lipton, Richard B Diener, Hans-Christoph Aurora, Sheena K Sirimanne, Mai DeGryse, Ronald E Turkel, Catherine C Dodick, David W Producer: 20140207 In: Journal of the neurological sciences vol. 331 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)